Colorectal liver metastases on gadoxetic acid-enhanced MRI: Typical characteristics decrease after chemotherapy

被引：0

作者：

van der Reijd, Denise J. ^{[1
,2
]}

Soykan, Ezgi A. ^{[1
,3
]}

Heeres, Birthe C. ^{[1
]}

Lambregts, Doenja M. J. ^{[1
,2
]}

Vollebergh, Marieke A. ^{[4
]}

Kuhlmann, Koert F. D. ^{[5
]}

Kok, Niels F. M. ^{[5
]}

Snaebjornsson, Petur ^{[6
,7
]}

Beets-Tan, Regina G. H. ^{[1
,8
]}

Maas, Monique ^{[1
,2
]}

Klompenhouwer, Elisabeth G. ^{[1
]}

机构：

[1] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands

[2] Maastricht Univ, GROW Sch Oncol & Reprod, Maastricht, Netherlands

[3] Univ Amsterdam, Canc Ctr Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands

[4] Antoni Van Leeuwenhoek Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands

[5] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands

[6] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands

[7] Univ Iceland, Fac Med, Reykjavik, Iceland

[8] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark

来源：

CLINICAL IMAGING | 2025年 / 119卷

关键词：

Magnetic resonance imaging; Liver; Colorectal cancer; Metastasis; Gadoxetic acid; Chemotherapy; GD-EOB-DTPA; PERILESIONAL ENHANCEMENT; HEPATIC METASTASES; CT; ACCURACY; IMPACT;

D O I：

10.1016/j.clinimag.2025.110417

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Purpose: To determine to what extent colorectal liver metastases (CRLM) display typical imaging characteristics on gadoxetic acid-enhanced magnetic resonance imaging (MRI) and what changes after chemotherapy. Methods: We retrospectively identified 258 patients with a gadoxetic acid-enhanced MRI between 2015 and 2021 and pathologically proven non-mucinous adenocarcinoma CRLM. 722 unique CRLMs were analyzed: 378 CRLM in only the chemotherapy-na & iuml;ve analysis; 217 in post-chemotherapy analysis; and 127 CRLM were analyzed both pre- and post-chemotherapy. The following six characteristics were defined as typical; "hypovascular", "unenhanced T1-weighted (UE-T1W) hypointensity", "arterial rim enhancement", "non-enhancing during hepatobiliary phase", "T2-weighted (T2W) mild hyperintensity", and "diffusion restriction". Results: All six typical characteristics were found in 249/505 chemotherapy-na & iuml;ve CRLM (49 %) and 87/344 post- chemotherapy CRLM (25 %). The occurrence of some typical characteristics decreased post-chemotherapy: UET1W hypointensity 485/505 (96 %) versus 311/336 (93 %), arterial rim enhancement 291/498 (58 %) versus 154/301 (51 %), T2W mild hyperintensity 478/505 (95 %) versus 269/338 (79 %), and diffusion restriction 435/497 (87 %) versus 200/306 (65 %). Almost all metastases showed a hypovascular appearance, both in the chemotherapy-na & iuml;ve (495/504, 98 %) and post-chemotherapy group (330/331, 100 %). Additionally, all CRLM appeared non-enhancing compared to the liver in the hepatobiliary phase (100 %). Conclusion: Most CRLM show various combinations of at least five typical characteristics on gadoxetic acid- enhanced MRI. Arterial rim enhancement is the least prevalent characteristic both in chemotherapy-na & iuml;ve and post-chemotherapy patients. Post-chemotherapy the occurrence of typical MRI characteristics decreases, especially mild T2W hyperintensity and the presence of diffusion restriction.

引用

页数：7

共 50 条

[21] Gadoxetic Acid-Enhanced Liver MRI Everything You Need to Know
Ichikawa, Shintaro
Goshima, Satoshi
INVESTIGATIVE RADIOLOGY, 2024, 59 (01) : 53 - 68
[22] Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis
Park, Hyo Jung
Lee, Seung Soo
Park, Bumwoo
Yun, Jessica
Sung, Yu Sub
Shim, Woo Hyun
Shin, Yong Moon
Kim, So Yeon
Lee, So Jung
Lee, Moon-Gyu
RADIOLOGY, 2019, 290 (02) : 380 - 387
[23] Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan
Jhaveri, Kartik S.
Fischer, Sandra E.
Hosseini-Nik, Hooman
Sreeharsha, Boraiah
Menezes, Ravi J.
Gallinger, Steven
Moulton, Carol-Anne E.
HPB, 2017, 19 (11) : 992 - 1000
[24] Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
S Islam
R Yin
A Riddell
H Tam
K Jhaveri
DM Koh
Cancer Imaging, 15 (Suppl 1)
[25] Role of gadoxetic acid-enhanced MRI in the differential diagnosis of chemotherapy-induced focal nodular hyperplasia-like lesions and liver metastases in patients with colorectal cancer
Chen, Yuan-yuan
Wang, Ming-liang
Li, Yi
Li, Jun
Yang, Li
Ding, Ying
Zeng, Meng-su
ABDOMINAL RADIOLOGY, 2025, 50 (04) : 1555 - 1563
[26] Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance
Canellas, Rodrigo
Patel, Midhir J.
Agarwal, Sheela
Sahani, Dushyant, V
EUROPEAN RADIOLOGY, 2019, 29 (11) : 5852 - 5860
[27] Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI
Palmucci, Stefano
WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 477 - 485
[28] Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI
Young Kon Kim
Young Hwan Lee
Chong Soo Kim
Min Woo Lee
Abdominal Imaging, 2011, 36
[29] Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI
Stefano Palmucci
World Journal of Hepatology, 2014, (07) : 477 - 485
[30] Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases
Mulder, B. G. Sibinga
Visser, K.
Feshtali, S.
Vahrmeijer, A. L.
Swijnenburg, R. J.
Hartgrink, H. H.
van den Boom, R.
Burgmans, M. C.
Mieog, J. S. D.
BMC MEDICAL IMAGING, 2018, 18

← 1 2 3 4 5 →